City

Atlanta (1)

Houston (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Phase

phase 2 (2)

Sponsor

Emory University (1)

M.D. Anderson Cancer Center (1)

Collaborator

Astellas Pharma Inc (1)

Merck Sharp & Dohme LLC (1)

National Cancer Institute (NCI) (1)

Seagen Inc. (1)

Intervention

biospecimen collection (1)

computed tomography (1)

enfortumab vedotin (1)

ipilimumab (1)

magnetic resonance imaging (1)

nivolumab (1)

pembrolizumab (1)

questionnaire administration (1)

tocilizumab (1)

Study Documents

Intervention Type

biological (2)

drug (1)

other (1)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

locally advanced bladder carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Tumor Trial in Atlanta (procedure,

Not yet recruiting

Bladder Squamous Cell Carcinoma
+10 more

Biospecimen Collection
+5 more

Atlanta, Georgia
+3 more

Feb 20, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

Recruiting

Clinical Stage III Cutaneous Melanoma AJCC v8
+41 more

Ipilimumab
+2 more

Houston, Texas

M D Anderson Cancer Center

Oct 11, 2022